Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2
Author:
Affiliation:
1. Health Division, Maccabi Healthcare Services, Tel Aviv, Israel
2. Internal Medicine and Infectious Diseases, Maccabi Healthcare Services, Haifa, Israel
Publisher
American Medical Association (AMA)
Subject
Neurology (clinical)
Link
https://jamanetwork.com/journals/jamaneurology/articlepdf/2783708/jamaneurology_shapiro_ben_david_2021_ld_210009_1636576276.47005.pdf
Reference5 articles.
1. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.;Vellozzi;Clin Infect Dis,2014
2. Guillain-Barré syndrome and influenza vaccines: a meta-analysis.;Martín Arias;Vaccine,2015
3. COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations.;Lunn;Brain,2021
4. Israeli Ministry of Health. Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/365_Corona.pdff.
5. Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https://www.cdc.gov/coronavirus/2019-ancov/vaccines/recommendations/underlying-conditions.html.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vaccine patterns among older adults with Guillain–Barré syndrome and matched comparators, 2006–2019;Journal of the American Geriatrics Society;2024-08
2. Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis;European Journal of Medical Research;2024-01-17
3. What Is the Impact of the Novel Coronavirus and the Vaccination on Guillain–Barre Syndrome?;Molecular Neurobiology;2023-09-20
4. Vaccine patterns among patients diagnosed with Guillain-Barré Syndrome and matched counterparts in a Medicare supplemental population, 2000–2020;Vaccine;2023-09
5. Pathophysiology, diagnosis, and management of neuroinflammation in covid-19;BMJ;2023-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3